Follow
Navaneethan Palanisamy
Navaneethan Palanisamy
Lecturer in Microbiology, Chester Medical School, University of Chester, UK
Verified email at chester.ac.uk - Homepage
Title
Cited by
Cited by
Year
Evaluation of Sofosbuvir (β-D-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine) as an inhibitor of Dengue virus replication#
HT Xu, SP Colby-Germinario, SA Hassounah, C Fogarty, N Osman, ...
Scientific reports 7 (1), 6345, 2017
812017
Implications of baseline polymorphisms for potential resistance to NS3 protease inhibitors in Hepatitis C virus genotypes 1a, 2b and 3a
N Palanisamy, A Danielsson, C Kokkula, H Yin, K Bondeson, L Wesslén, ...
Antiviral research 99 (1), 12-17, 2013
772013
Influenza A virus encoding secreted Gaussia luciferase as useful tool to analyze viral replication and its inhibition by antiviral compounds and cellular proteins
N Eckert, F Wrensch, S Gärtner, N Palanisamy, U Goedecke, N Jäger, ...
PloS one 9 (5), e97695, 2014
652014
A Multicolor Large Stokes Shift Fluorogen-Activating RNA Aptamer with Cationic Chromophores
C Steinmetzger, N Palanisamy, KR Gore, C Höbartner
Chemistry- A European Journal 25 (8), 1931-1935, 2019
492019
Prevalence of polymorphisms with significant resistance to NS5A inhibitors in treatment-naive patients with hepatitis C virus genotypes 1a and 3a in Sweden
I Lindström, M Kjellin, N Palanisamy, K Bondeson, L Wesslén, ...
Infectious diseases 47 (8), 555-562, 2015
472015
Engineering AraC to make it responsive to light instead of arabinose
E Romano, A Baumschlager, EB Akmeric, N Palanisamy, M Houmani, ...
Nature chemical biology 17 (7), 817-827, 2021
452021
Split intein-mediated selection of cells containing two plasmids using a single antibiotic
N Palanisamy, A Degen, A Morath, J Ballestin Ballestin, C Juraske, ...
Nature communications 10 (1), 4967, 2019
222019
Worldwide prevalence of baseline resistance-associated polymorphisms and resistance mutations in HCV against current direct-acting antivirals
N Palanisamy, P Kalaghatgi, D Akaberi, Å Lundkvist, Z Chen, P Hu, ...
Antiviral Therapy 23 (6), 485-493, 2018
212018
Nutritional status of children in rural India: a case study from Tamil Nadu, first in the world to initiate the Mid-Day Meal scheme
P Navaneethan, T Kalaivani, C Rajasekaran, N Sunil
Health 3 (10), 647, 2011
212011
Targeting the NS2B-NS3 protease of tick-borne encephalitis virus with pan-flaviviral protease inhibitors
D Akaberi, A Båhlström, PK Chinthakindi, T Nyman, A Sandström, ...
Antiviral Research 190, 105074, 2021
162021
Cross-cultural ethnobotany and conservation of medicinal and aromatic plants in the Nilgiris, Western Ghats: A case study
N Palanisamy, N Sunil, K Thiagarajan, R Chandrasekaran
Medicinal Plants - International Journal of Phytomedicines and Related …, 2011
142011
Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden …
M Kjellin, H Kileng, D Akaberi, N Palanisamy, AS Duberg, A Danielsson, ...
Scandinavian Journal of Gastroenterology 54 (8), 1042-1050, 2019
132019
Global prevalence of adaptive and prolonged infections’ mutations in the receptor-binding domain of the SARS-CoV-2 spike protein
J Lennerstrand, N Palanisamy
Viruses 13 (10), 1974, 2021
122021
Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease
D Akaberi, PK Chinthakindi, A Båhlström, N Palanisamy, A Sandström, ...
Journal of Biomolecular Structure and Dynamics 38 (18), 5526-5536, 2020
122020
Does antiretroviral treatment change HIV-1 codon usage patterns in its genes: a preliminary bioinformatics study
N Palanisamy, N Osman, F Ohnona, HT Xu, B Brenner, T Mesplède, ...
AIDS Research and Therapy 14 (2), 2017
122017
Protein backbone flexibility pattern is evolutionarily conserved in the Flaviviridae family: A case of NS3 protease in Flavivirus and Hepacivirus
N Palanisamy, D Akaberi, J Lennerstrand
Molecular phylogenetics and evolution 118, 58-63, 2018
112018
Computational prediction of Usutu virus E protein B cell and T cell epitopes for potential vaccine development
N Palanisamy, J Lennerstrand
Scandinavian journal of immunology 85 (5), 350-364, 2017
112017
Transmission of hepatitis C virus among intravenous drug users in the Uppsala region of Sweden
A Danielsson, N Palanisamy, S Golbob, H Yin, J Blomberg, J Hedlund, ...
Infection ecology & epidemiology 4 (1), 22251, 2014
112014
SARS-CoV-2 variants of concern and spike protein mutational dynamics in a Swedish cohort during 2021, studied by Nanopore sequencing
S Mannsverk, J Bergholm, N Palanisamy, P Ellström, R Kaden, J Lindh, ...
Virology Journal 19 (1), 164, 2022
102022
Baseline dasabuvir resistance in Hepatitis C virus from the genotypes 1, 2 and 3 and modeling of the NS5B-dasabuvir complex by the in silico approach
D Akaberi, A Bergfors, M Kjellin, N Kameli, L Lidemalm, B Kolli, ...
Infection Ecology & Epidemiology 8 (1), 1528117, 2018
92018
The system can't perform the operation now. Try again later.
Articles 1–20